OptiCell Solutions participates in ATMP Sweden 2024, Malmö 25-25 November

PRESS RELEASE, Huddinge Sweden 15-OCT-2024

OptiCell Solutions improving access to high quality target cells for Cell and Gene Therapy

ATMP Sweden 2024 in Malmö 25-26 November

Of course, we´re going! Wouldn’t miss it for the world.
We have a special event in Sweden which trying to bring in all Swedish ATMP stakeholders.
It makes for an interesting network, where the stakeholders are better informed about the other competencies required in the space.
We believe this event will help to build effective collaborations.
Will we see you in November?
Come and meet us to discuss our services in Cell and Gene therapy, we have booth number 25.
See you there!

ATMP Sweden

About OptiCell Solutions

Founded in 2024, OptiCell Solutions AB specializing in the field of apheresis and cell collection for gene and cell therapies (CAGT). By using our advanced apheresis technology, we can collect large quantities of specific donor cells, significantly advancing CAGT applications within in the biotech and healthcare sector.

Furthermore, our extensive experience and know-how in apheresis enable us to offer specialized therapeutic apheresis service to the healthcare sector. We are providing the industry and healthcare sector with services in setting up and coordinating clinical trials in the CAGT field.

Located near the Karolinska University Hospital in Huddinge we aim to bridge the gap in resources by offering innovative solutions that enhance the availability of essential cells for groundbreaking research and life-saving therapies.

With our deep expertise in apheresis technology and a strong commitment to ethical research practices, we are dedicated to improving patient outcomes and supporting the development of next-generation therapies for cancer, autoimmune diseases, and other severe medical conditions.

At OptiCell Solutions, we strive to be at the forefront of medical innovation, providing the tools and services necessary to accelerate the transition to more effective and patient-centred care.

PRESS RELEASE 15OCT2024

END PRESS RELEASE

Opticell Solution

Visiting address

OptiCell Solutions AB

Via Hälsovägen 7, Elevator A, Floor 7

Via Blickagången 6A, Elevator A, Floor 7

141 57 Huddinge, Sweden

Mailing address

OptiCell Solutions

Novum Labs

Hälsovägen 7, Floor 5, Elevator E, Box 1

141 57 Huddinge, Sweden

Registration number: 559473-6125

Information

Quality Management System

Privacy Policy

GCP - ICH guideline for good clinical practice
Audits from Medicines Agency, IVO, Biotech companies, Healthcare sector, The Pharmacy

Board of directors

Please visit www.allabolag.se

Annual Report

Please visit www.allabolag.se

IVO Register

Owners

CliniQnect AB, Jarmo Henriksson, Peter Rybäck, Patrik Åvestrand

Copyright © 2024 OptiCell Solutions AB. All rights reserved.